Received Jul 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 3275B | — |
received an expired dose of Menveo (1 vial); This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number 3275B, expiry date 30-JUN-2025) for prophylaxis. On 16-JUL-2025, the patient received Menveo. On 16-JUL-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: received an expired dose of Menveo (1 vial)). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 16-JUL-2025 The reporter reported the administration of an expired dose of Menveo (1 vial) to a patient, which led to expired vaccine used The reporter asked would the patient need to be revaccinated and was there a time frame window to receive again the dose.